Browse
Submit Data
Databases
API
Help

Dataset Information

20 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

[Bis(3,5-dimethyl-pyrazol-1-yl)methane]{N-[1-(2-oxidophen-yl)ethyl-idene]-dl-alaninato}copper(II) monohydrate.

ABSTRACT: In the title compound, [Cu(C(11)H(11)NO(3))(C(11)H(16)N(4))]·H(2)O, the Cu(II) atom is five-coordinate in a distorted square-pyramidal geometry. The basal positions are occupied by three donor atoms from the tridentate Schiff base ligand and by one N atom from a bis-(3,5-dimethyl-prazol-l-yl)methane ligand. The apical position is occupied by the N atom of the other ligand of this type. There are only van der Waals contacts in the crystal structure.

SUBMITTER: Zhao GQ

PROVIDER: S-EPMC2960032 | biostudies-literature | 2008 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

[Bis(3,5-dimethyl-pyrazol-1-yl)methane]{N-[1-(2-oxidophen-yl)ethyl-idene]-dl-alaninato}copper(II) monohydrate.

Zhao Gan-Qing GQ Xue Ling-Wei LW Hao Cheng-Jun CJ Chen Li-Hua LH Wu Hua-Tao HT

Acta crystallographica. Section E, Structure reports online 20081113 Pt 12

In the title compound, [Cu(C(11)H(11)NO(3))(C(11)H(16)N(4))]·H(2)O, the Cu(II) atom is five-coordinate in a distorted square-pyramidal geometry. The basal positions are occupied by three donor atoms from the tridentate Schiff base ligand and by one N atom from a bis-(3,5-dimethyl-prazol-l-yl)methane ligand. The apical position is occupied by the N atom of the other ligand of this type. There are only van der Waals contacts in the crystal structure. ...[more]

PMID: 21581163

Similar Datasets

Chlorido[1-(2-oxidophen-yl)ethyl-idene][tris-(3,5-dimethyl-pyrazol-1-yl)hydro-borato]iridium(III) chloro-form monosolvate.

Project description:In the title compound, [Ir(C15H22BN6)(C8H7O)Cl]·CHCl3, the Ir atom is formally trivalent and is coordinated in a slightly distorted octa-hedral geometry by three facial N atoms, one C atom, one O atom and one Cl atom. The Ir=Ccarbene bond is strong and short and exerts a notable effect on the trans-Ir-N bond, which is about 0.10 Å longer than the two other Ir-N bonds. The chloro-form solvent mol-ecule is anchored via a weak C-H⋯Cl hydrogen bond to the Cl atom of the Ir complex mol-ecule. In the crystal, the constituents adopt a layer-like arrangement parallel to (010) and are held together by weak inter-molecular C-H⋯Cl hydrogen bonds, as well as weak Cl⋯Cl [3.498 (2) Å] and Cl⋯π [3.360 (4) Å] inter-actions. A weak intra-molecular C-H⋯O hydrogen bond is also observed.

| S-EPMC3629499 | biostudies-literature

Aqua-{N-[1-(2-oxidophen-yl)ethyl-idene]-l-serinato}copper(II) monohydrate.

Project description:In the title compound, [Cu(C(11)H(11)NO(4))(H(2)O)]·H(2)O, each Cu(II) ion is four-coordinated by one N and two O atoms from the tridentate Schiff base ligand, and by one O atom from the coordinated water mol-ecule in a distorted square-planar geometry. Inter-molecular O-H?O hydrogen bonds link complex mol-ecules and solvent water mol-ecules into flattened columns propagated in [100].

| S-EPMC2972012 | biostudies-literature

Bis{4-[(3,5-dimethyl-1H-pyrazol-4-yl)selan-yl]-3,5-dimethyl-1H-pyrazol-2-ium} chloride monohydrate.

Project description:In the title compound, 2C(10)H(15)N(4)Se(+)·Cl(-)·OH(-), a singly protonated mol-ecule of the organic selenide participates in hydrogen bonding with neighboring mol-ecules, forming zigzag chains along [001]. The molecule adapts a cis bridging mode with a C-Se-C angle of 102.13 (15)°. π-π stacking inter-actions are observed between the closest pyrazole rings of neighboring chains [centroid-centroid distance = 3.888 (1) Å] and hydrogen bonding occurs through bridging chloride anions and hydroxide groups. Additionally, O-H⋯Cl hydrogen bonds are formed.

| S-EPMC3393332 | biostudies-literature

catena-Poly[[[(3,5-dimethyl-1H-pyrazole)-copper(II)]-μ-{N-[1-(2-oxidophen-yl)ethyl-idene]-l-valinato}] methanol monosolvate].

Project description:The asymmetric unit of the title compound, {[Cu(C(13)H(15)NO(3))(C(5)H(8)N(2))]·CH(3)OH}(n), contains two complex mol-ecules and two solvent mol-ecules. Each Cu(II) ion is in a distorted square-pyramidal coordination with one N and two O atoms from the Schiff base ligand and one N atom from the heterocycle in the basal positions and one carboxyl-ate O atom from a neighbouring ligand in the apical position. The apical Cu-O bonds are much longer than the basal Cu-O and Cu-N bonds. The carboxyl-ate groups of the Schiff base ligands bridge the Cu(II) ions, forming helical chains along [100]. The crystal packing is stabilized by inter-molecular O-H⋯O and N-H⋯O hydrogen bonds.

| S-EPMC3051769 | biostudies-literature

2-(3,5-Dimethyl-1H-pyrazol-1-yl)-2-hy-droxy-imino-N'-[1-(pyridin-2-yl)ethyl-idene]acetohydrazide.

Project description:In the title compound, C14H16N6O2, the dihedral angles formed by the mean plane of the acetohydrazide group [maximum deviation 0.0629 (12) Å] with the pyrazole and pyridine rings are 81.62 (6) and 38.38 (4)° respectively. In the crystal, mol-ecules are connected by N-H⋯O and O-H⋯N hydrogen bonds into supra-molecular chains extending parallel to the c-axis direction.

| S-EPMC3588977 | biostudies-literature

N'-[(E)-1-(3,5-Dichloro-2-hy-droxy-phen-yl)ethyl-idene]-4-meth-oxy-benzo-hydrazide monohydrate.

Project description:The title compound, C(16)H(14)Cl(2)N(2)O(3)·H(2)O, displays a trans conformation with respect to the C=N double bond. The dihedral angle between the two benzene rings is 4.98?(12)°. Intra-molecular O-H?N and O-H?O hydrogen bonds occur. The crystal structure is stabilized by inter-molecular O-H?O and N-H?O hydrogen bonds. In addition, there are ?-? inter-actions between the chemically distinct benzene rings of inversion-related mol-ecules [centroid-centroid separation = 3.715?(1)?Å].

| S-EPMC2983383 | biostudies-literature

Di-n-but-yl{1-[1-(2-hydroxy-phen-yl)ethyl-idene]-5-[1-(2-oxidophen-yl)ethyl-idene]thio-carbazonato-?O,N,S}tin(IV).

Project description:The 'symmetrical' 1,5-bis-[1-(2-hydroxy-phen-yl)ethyl-idene]thio-carbazone Schiff base condenses with dibutyl-tin oxide to form the title complex, [Sn(C(4)H(9))(2)(C(17)H(16)N(4)O(2)S)], in which the deprotonated ligand O,N,S-chelates to the Sn atom of two crystallographically independent mol-ecules. The ligand bears a formal negative charge on the S and one O atom; the other O atom retains its H atom. The Sn atoms are five-coordinated in a cis-C(2)NOSSn trigonal-bipyramidal environment, and the apical sites are occupied by the O and S atoms. In both mol-ecules, the hydr-oxy group is hydrogen bonded to a double-bonded N atom, generating a six-membered ring. The amino group is a donor to the coordinated O atom of an adjacent mol-ecule, the hydrogen-bonding inter-action giving rise to a helical chain running along the b axis. In one of the independent mol-ecules, the atoms of one of the n-butyl groups are disordered over two sets of sites with equal occupancy. In the other independent mol-ecule, the atoms of both n-butyl groups are disordered over two sets of sites with equal occupancy and, in addition, the Sn and S atoms were also refined as disordered over two sets of sites with equal occupancy.

| S-EPMC2979428 | biostudies-literature

{N'-[(E)-1-(5-Bromo-2-oxidophen-yl)ethyl-idene]-4-chloro-benzohydrazidato}pyridinenickel(II).

Project description:The title complex, [Ni(C(15)H(10)BrClN(2)O(2))(C(5)H(5)N)], displays a square-planar coordination geometry around the Ni(II) ion, formed by the tridentate hydrazone and monodentate pyridine ligands, with the N atoms in a trans arrangement about the Ni center.

| S-EPMC2969398 | biostudies-literature

{4-Dimethyl-amino-N'-[1-(2-oxidophen-yl)ethyl-idene]benzohydrazidato}(methano-lato)oxidovanadium(V).

Project description:The title oxidovanadium(V) complex, [V(C(17)H(17)N(3)O(2))(CH(3)O)O], was obtained by the reaction of 2-acetyl-phenol, 4-dimethyl-amino-benzohydrazide and vanadyl sulfate in methanol. The V(V) atom is five-coordinated by N,O,O'-donor atoms of the Schiff base ligand, one meth-oxy O atom and one oxide O atom, forming a square-pyramidal geometry.

| S-EPMC3238735 | biostudies-literature

A second monoclinic polymorph of 2-(3,5-dimethyl-1H-pyrazol-1-yl)-2-hy-droxy-imino-N'-[1-(pyridin-2-yl)ethyl-idene]acetohydrazide.

Project description:The title compound, C14H16N6O2, is a second monoclinic polymorph of 2-[1-(3,5-dimeth-yl)pyrazol-yl]-2-hy-droxy-imino-N'-[1-(2-pyrid-yl)ethyl-idene] acetohydrazide, with two crystallographically independent mol-ecules per asymmetric unit. The non-planar mol-ecules are chemically equal having similar geometric parameters. The previously reported polymorph [Plutenko et al. (2012 ?). Acta Cryst. E68, o3281] was described in space group Cc (Z = 4). The oxime group and the O atom of the amide group are anti with respect to the C-C bond. In the crystal, mol-ecules are connected by N-H?N hydrogen bonds into zigzag chains extending along the b axis.

| S-EPMC3648291 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data